AbbVie Aktie

188,00 EUR +0,60 EUR +0,32 %

07:56:44

BMN

220,04 USD +0,01 USD ±0,00 %

nachbörslich24.09.2025

BTT

AbbVie jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.334,83 Mrd. EUR

KGV74,34Div. Rendite3,54%

WKNA1J84E

ISINUS00287Y1091

SymbolABBV

AbbVie Aktien News

Sortieren:Datum Meistgelesen

20.03.25MotleyFoolHere's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends

18.03.25ZacksAbbVie (ABBV) Stock Moves -0.29%: What You Should Know

17.03.25ZacksThe Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands

15.03.25PR NewswireELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients

14.03.25ZacksTop Analyst Reports for AbbVie, Lockheed Martin & Dell

13.03.25ZacksAbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

11.03.25ZacksWhy AbbVie (ABBV) Dipped More Than Broader Market Today

10.03.25ZacksZacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie

07.03.25BenzingaAbbVie Options Trading: A Deep Dive into Market Sentiment

05.03.25ZacksHere's How to Play AbbVie Stock as it Enters the Obesity Space

04.03.25Benzinga13 Analysts Have This To Say About AbbVie

04.03.25PR NewswireAbbVie to Present at the Leerink Partners Global Healthcare Conference

04.03.25PR NewswireSKYRIZI® (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease

03.03.25ZacksAbbVie (ABBV) Rises As Market Takes a Dip: Key Facts

03.03.25BenzingaAbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race

03.03.25PR NewswireAbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity

28.02.25PR NewswireAbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis

26.02.25ZacksAbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It

26.02.25PR NewswireAbbVie to Present at the TD Cowen's 45th Annual Health Care Conference

24.02.25BenzingaHere's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years

24.02.25ZacksThe Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

15.02.25MotleyFoolIs AbbVie Stock a Buy Now?

14.02.25PR NewswireAbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors

13.02.25PR NewswireAbbVie Declares Quarterly Dividend

12.02.25PR NewswireAllergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training

12.02.25PR NewswireAbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

07.02.25PR NewswireU.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options

07.02.25ZacksThe Zacks Analyst Blog Walmart, Visa, AbbVie and AstroNova

06.02.25ZacksEarnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie

06.02.25ZacksInvestors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

05.02.25ZacksAbbVie Rises 8% Since Q4 Earnings: Buy, Hold or Sell the Stock?

31.01.25MotleyFoolAbbVie (ABBV) Q4 2024 Earnings Call Transcript

31.01.25ZacksAbbVie Beats on Q4 Earnings & Sales, Raises Sales View for Key Drugs

31.01.25MotleyFoolWhy AbbVie Stock Is Jumping Today

31.01.25BenzingaCharter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday

31.01.25BenzingaAbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline

31.01.25ZacksCompared to Estimates, AbbVie (ABBV) Q4 Earnings: A Look at Key Metrics

31.01.25ZacksAbbVie (ABBV) Q4 Earnings and Revenues Surpass Estimates

31.01.25Benzinga$100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today

30.01.25BenzingaAbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings?

AbbVie News

AbbVie News: auf dieser Seite finden Sie alle AbbVie News und Nachrichten zur AbbVie Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AbbVie News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AbbVie News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.